It reported revenues of ₹6,705 crore and loss of ₹304 crore in FY23. While the offline pharmacy distribution business generated earnings before interest, tax, depreciation and amortisation (Ebitda) of ₹534 crore in FY23, growing 31% year-on-year (YoY), the digital health business has been burning cash on an average to the tune of ₹180 crore per quarter.
